SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020346
Filing Date
2021-04-23
Accepted
2021-04-23 16:12:10
Documents
6
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A tcon-def14a_20210610.htm DEF 14A 1406128
2 GRAPHIC gf4wcdcg5umr000003.jpg GRAPHIC 24558
3 GRAPHIC gf4wcdcg5umr000001.jpg GRAPHIC 12234
4 GRAPHIC gf4wcdcg5umr000005.jpg GRAPHIC 137529
5 GRAPHIC gf4wcdcg5umr000002.jpg GRAPHIC 24558
6 GRAPHIC gf4wcdcg5umr000004.jpg GRAPHIC 197728
  Complete submission text file 0001564590-21-020346.txt   1953866
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36818 | Film No.: 21849837
SIC: 2836 Biological Products, (No Diagnostic Substances)